Rising stimulant use is driving a new trend in national overdose deaths. While no medication has been FDA-approved for stimulant addiction, a handful demonstrate off-label evidence. These include ...

However, patients who received their initial stimulant prescription through telehealth were at a higher risk of developing a stimulant use disorder after adjusting for other factors. Stimulant use ...

Stimulant use disorder involves drugs such as prescription medications, cocaine or methamphetamine, among other drugs. Patients aged 26 years and above who received an initial stimulant prescription ...

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, affecting 12%–13% of adolescents in the United States, according to some studies. The pattern of inattention, ...

About The Study: Although access to prescription stimulants is essential to addressing important clinical needs of patients with attention-deficit/hyperactivity ...

Stimulants, primarily amphetamines and methylphenidate, are increasingly prescribed to treat attention-deficit/hyperactivity disorder (ADHD) in adults — raising ...

This transcript has been edited for clarity. Carolyn A. Chan, MD: Welcome. I'm Dr Carolyn Chan. I'm joined by my good friend and co-host, Dr Natalie Stahl. Natalie, how are you doing today? Natalie ...

About one in six working adults in the U.S. battle a substance use disorder, and nearly 10% of U.S. employees have a cannabis or stimulant use disorder. Recognizing this, Carrum Health has expanded ...

Psychostimulants, including amphetamine-type stimulants and methylphenidate, are most often prescribed to treat attention-deficit/hyperactivity disorder (ADHD). In ...

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...